Back
Alkermes PLC Vs. Iterum Therapeutics PLC Industry Stock Comparison
Buy
52
ALKS
Alkermes PLC
Last Price:
28.77
Seasonality Move:
23.4%
Buy
78
ITRM
Iterum Therapeutics PLC
Last Price:
1.80
Seasonality Move:
52.64%
Buy
52
Alkermes PLC (ALKS)
is a Buy
Is Alkermes PLC a Buy, Sell or Hold?
- The current Alkermes PLC [ALKS] share price is $28.78. The Score for ALKS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ALKS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Iterum Therapeutics PLC (ITRM)
is a Buy
Is Iterum Therapeutics PLC a Buy, Sell or Hold?
- The current Iterum Therapeutics PLC [ITRM] share price is $1.81. The Score for ITRM is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- ITRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $28.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALKS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITRM Stock Price Chart
What is Iterum Therapeutics PLC's stock price today?
-
The Iterum Therapeutics PLC share price today is $1.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITRM is experiencing slight buying pressure.
ALKS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 55.45 | Buy |
Chaikin Money Flow: | 1179441 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.64 - 28.94) | Buy |
Bollinger Bands (100): | (25.7 - 28.68) | Buy |
ITRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 69.04 | Buy |
Chaikin Money Flow: | 407921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.17 - 1.59) | Buy |
Bollinger Bands (100): | (1.02 - 1.4) | Buy |
ALKS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.15 | Buy |
20-day SMA: | 27.9 | Buy |
50-day SMA: | 27.87 | Buy |
200-day SMA: | 26.6 | Buy |
8-day EMA: | 28.18 | Buy |
20-day EMA: | 28.08 | Buy |
50-day EMA: | 27.78 | Buy |
200-day EMA: | 26.99 | Buy |
ITRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Buy |
20-day SMA: | 1.41 | Buy |
50-day SMA: | 1.21 | Buy |
200-day SMA: | 1.33 | Buy |
8-day EMA: | 1.59 | Buy |
20-day EMA: | 1.44 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 1.3 | Buy |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and a decrease next year of $0.83 per share.
Iterum Therapeutics PLC Earnings Growth & ITRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.53 per share, and an increase next year of $0.21 per share.
Alkermes PLC Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Iterum Therapeutics PLC Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |